To further verify the role of FOXO3 and ZFP36 in modulating UPR-mediated chemoresistance in MM, we examined the activation of UPR pathway regulators following shRNA-mediated KD of both genes in parental KMS11 cells. This evidence concerns the gene FOXO3 and Miyoshi myopathy.